The effects of long-term exposure of primary cultured rat dorsal root ganglion (DRG) cells to bradykinin (BK), compared to short-term exposure, were investigated to establish whether BK could induce prostaglandin E2 (PGE2) release from DRG cells. Short-term exposure (30 min) resulted in a small but significant amount of PGE2 release which was mainly inhibited by a selective COX-1 inhibitor, SC-560 but only partially by a selective COX-2 inhibitor, NS-398, and did not induce COX-2 protein as determined by Western blotting. In contrast, long-term exposure (3 hr) induced a large amount of PGE2 release, which was completely abolished by indomethacin or NS-398. The level of COX-2 mRNA began to be detected by ribonuclease protection assay after 30 min of 100 nM BK exposure, maintained maximal expression for 1 h, and subsequently declined to the basal level. The level of COX-2 protein was expressed to follow the time course of COX-2 mRNA induction by BK in a delayed but similar kinetic manner. The expression of COX-2 induced by BK in DRG cells was inhibited by a BK B2 receptor antagonist, HOE140, but not a B1 receptor antagonist, Lys-des-Arg 9 , (Leu 8 )-BK. Thus BK has been shown to induce COX-2 protein by B2
Bradykinin (BK) acts as an endogenous algesic substance on sensory neurons with the activation and sensitization of nociceptors to cause acute pain and hyperalgesia associated with inflammation, nerve injury, or rheumatinoid diseases [10] .
By short-term exposure in DRG cells, BK could stimulate B2 receptor constitutively expressed in a subpopulation of rat primary sensory neurons [27] , sensitize transient receptor potential vanilloid receptor 1 (TRPV1) by release from phosphatidylinositol 4,5-bisphosphate-mediated inhibition [9] , and activate protein kinase C, which phosphorylates TRPV1, resulting in the sensitization of TRPV1 [21] . We have observed that BK sensitizes TRPV1 to facilitate capsaicin-induced 45 
Ca
2+ uptake by the activation of phospholilpase C in primary cultured rat dorsal root ganglion (DRG) cells [30] .
On the other hand, sensitization by BK might involve long-term changes in gene expression. BK
stimulates the production and release of a number of endogenous chemicals, for example neuropeptides such as substance P and calcitonin gene-related peptide, cytokines such as interleukin-1β and TNF-α, 5-HT, ATP, histamine and prostanoids which can mediate neurogenic inflammation and inflammation-induced hyperalgesia [10] . There are some reports that BK induces prostaglandin E2 (PGE2) release from some cell types. For example, Jenkins et al. [13] demonstrated that BK induced PGE 2 release from cultured rat trigeminal ganglion neurons.
Furthermore, Pang et al. [23] reported that BK-stimulated PGE 2 release and BK-induced activation of cyclooxygenase (COX)-2 were inhibited by cycloheximide in human airway smooth muscle cells.
Two isoforms of COX, COX-1, and COX-2 have been identified, the former constitutively expressed in many cell types and possibly activated by short-term treatment with BK and the latter induced at the site of inflammation [31] . Recent works have reported that BK induced prostanoid production owing to the induction of COX-2 isoform in cultured fibroblasts [29] , pulmonary artery smooth muscle cells [5] , and human airway epithelial cells [7] . Thus COX-2 induction by BK in DRG cells may be involved in the excitation and sensitization of sensory neurons contributing inflammation-induced hyperalgesic sensations, which has not been demonstrated.
Thus, we investigated PGE2 release by exposing primary cultured rat DRG cells to BK as a function of the treatment time associated with the change of COX activity. We found that long-term exposure to BK induced the transient expression of COX-2 mRNA and protein via B2 receptor, which was responsible for the production and release of PGE2 in DRG cells.
Male Wistar rats weighing 200-300 g were housed in cages under a 12 h light/dark cycle and given access to food and water ad libitum. All procedures used in these studies were approved by the Animal Care and Use Committee of Hiroshima University, Hiroshima, Japan. The rat DRG were digested with 0.125% collagenase and 0.25% trypsin and mechanically dissociated by trituration.
The cells were plated in 35 mm-diameter tissue culture dishes coated with polyethyleneimine and laminin and maintained at 37℃ under an atmosphere of 5% CO2 in Dulbecco's modified Eagle's medium supplemented with 10% horse serum, 2 mM glutamine, 50 mg/ml penicillin-streptomycin, and 50 ng/ml 2.5S mouse salivary gland nerve growth factor. The medium was changed every 3 days. The cultured rat DRG cells were treated with drugs tested on day 5 of culture. On the day, neurons exhibited globular cell bodies and slender axonal processes. Many non-neuronal cells such as Schwann cells and fibroblasts were present in the background.
PGE2 content in the culture medium was determined by enzyme immunoassay (Amersham Biosciences Co., Piscataway, NJ, USA) according to the manufacturer's protocol.
Total RNA in culture cells was prepared according to the method of Chomzynski and Sacchi [8] .
The cDNAs encoding rat COX-2 (pCX2) and β-actin were prepared by reverse transcription PCR as described previously [12] . Ribonuclease protection assay was performed as described previously [12] . Briefly the radiolabeled antisense RNA probe for COX-2 and β-actin was added to 10 μg total RNA in hybridization buffer and incubated at 45℃ for 12 h. After the mixture was digested with 40 μg/ml RNase A at 30℃ for 1h and treated with proteinase K, the resulting hybridized RNA was analyzed by electrophoresis on a 4% polyacrylamide/7 M urea gel. The intensity of each band on the gel was analysed using a model BAS2000 bioimaging analyzer (Fuji Film, Tokyo, Japan).
To determine the expression of COX-2 protein, DRG cells treated with BK (Peptide Institute
Inc., Osaka, Japan) were lysed in 100 μL of lysis buffer containing 20 mM Tris/HCl, pH 7.5, 150
mM NaCl, 1% Nonidet P-40, 10% glycerol, 20 μg/mL aprotinin, 20 μg/mL leupeptin, and 1 mM PMSF, and the lysate was centrifuged at 20,000 g for 10min at 4℃. The supernatant ( Immunoreactivity was detected using an enhanced chemiluminescence (ECL) detection system (Bio-Rad Lab, Inc., Hercules, CA, USA) and exposure to X-ray film (Fuji Film Tokyo Japan), and was quantified using software (Fuji Film, Tokyo, Japan).
Data are expressed as the mean ± SE values. The PGE2 amounts released and the relative levels of band intensity of the electrophoresis were evaluated by one-way ANOVA with pairwise comparison by the Bonferroni method. Differences were considered significant when the p value was <0.05.
As shown in Fig. 1a , short-term exposure of the DRG to BK at 1μM for 30 min induced small but significant amounts of PGE2 release, while long-term exposure of BK at 1μM for 3 h facilitated more than 8x PGE2 release compared with non-treated cells. (Fig. 2a , c) . (Fig. 3b) .
We showed that the long-term, not short-term, exposure of primary cultured rat DRG cells to BK is responsible for PGE2 production by COX-2 activation. To our knowledge, this study is the first to demonstrate directly that BK induces COX-2 protein in rat DRG cells and that this induction is involved in BK-induced PGE2 generation. In human airway epithelial cells, BK has been shown to act through B2 receptor and activate the Ras/Raf-1/ERK pathway, which increases IκB kinase activity and finally induces NF-κB activation [7] . We have demonstrated that the effects of BK in this study are mediated by B2 receptor and preliminary observed that COX-2 protein production by BK was inhibited by U0126, a inhibitor of ERK (data not shown). Thus, possible similar mechanisms to airway epithelial cells might underlie our DRG cells leading to COX-2 expression by long-term exposure to BK, and are now under investigation.
The early release of PGE2 by BK exposure for 30 min was significantly inhibited by COX-1 inhibitor, suggesting that constitutive COX-1 is responsible for PGE2 production in short-term treatment. In our DRG cells, COX-1 mRNA was constitutively expressed [12] whether the cells were treated with BK or not. While NS-398 caused the small but significant inhibition of the early PGE2 release, maybe because the functional amount of COX-2 protein produced by 30 min exposure was too small to be detected by Western blotting analysis. Indeed, COX-2 mRNA was already expressed significantly at 30 min treatment (Fig. 2) .
The change in COX-2 protein accumulation follows very closely the kinetic of COX-2 mRNA expression, which was rapid and transient. This indicates that DRG cells have a high rate system of COX-2 turnover. Previous studies in our laboratory [12] have shown that interleukin-1β, a proinflammatory cytokine, induced the rapid appearance of COX-2 mRNA followed by a declining phase, and the steady-state expression persisted until 24 h. In WISH cells, the rapid and transient expression of COX-2 was induced by epidermal growth factor [24] , while the steady-state expression of COX-2 mRNA and increasing accumulation of COX-2 protein for 24 h were induced by IL-1β and TNF [1] . Thus, the persistence of COX-2 expression is greatly influenced by the stimulus employed.
Two subtypes of BK receptors, B1 and B2, have been cloned from the rat genome [18, 20] , and their mediated responses can be distinguished pharmacologically by the effective potencies of BK receptor ligands. The inhibitory effects of selective antagonists on COX-2 mRNA and protein production and PGE2 release suggests that the actions of BK-induced COX-2 expression in DRG cells are mediated by B2 receptors. B2 receptors are constitutively expressed in a subpopulation of rat DRG neurons [27] and are upregulated in response to nerve injury [25] ; however, there are contradictory reports about the existence of B1 receptors in rat DRG neurons. Some detected B1
receptor mRNA by RT-PCR in normal DRG [15, 17] , and another indicated the lack of B1 receptor expression in both normal conditions and after nerve injury [6] . In our results, the selective B2-receptor antagonist HOE140 completely abolished the effects of BK, suggesting no contribution of B1 receptors in BK actions in our cultured rat DRG cells.
BK induces sensory neuron excitation and sensitization of nociceptors, which probably underlies the phenomenon of peripheral hyperalgesia during inflammation. BK is not only a powerful inflammatory mediator by itself [10] but can directly activate cPLA2 to release arachidonic acid [11] and induce COX-2 expression. Consequently, BK induces exaggerated prostanoid production around sensory neurons. Prostanoids have long been known to sensitize sensory neurons to facilitate the release of neuropeptides such as substance P, neurokinin A and calcitonin gene related peptide [19, 28] , which mediate neurogenic inflammation and contribute to nociceptor sensitization in an autocrine manner. We observed that BK induced the facilitation of capsaicin-evoked substance P release by long-term treatment for 3 h in our rat cultured DRG cells [22] .
The rat cultured DRG cells we used were fed with 50 ng/mL NGF. NGF has several important effects on the morphological and functional properties of sensory neurons. Although the cultured DRG cells from a fetus or newborn rats cannot survive without NGF, adult rat cultured DRG cells can survive without NGF. However, the phenotype of adult rat cultured DRG cells changes with NGF, which enhances the sensitivity of DRG neurons to capsaicin and noxious heat [4] , and increases the expression of substance P, TrkA receptor, TRPV1, and P2X3 ATP receptors [2, 3, 16, 26] . These events may be reflected in the facilitation of processing nociceptive signals. This preparation might therefore reflect the pathophysiological conditions of inflammation-induced hyperalgesia. In the case of B2 receptors, NGF has been reported to increase B2 receptor expression in mouse DRG [14] ; however, we observed no effects of NGF on B2 receptor mRNA levels in our DRG cells (data not shown) and the question of whether our DRG cells reflect pathophysiological conditions remains unclear and is under study.
In conclusion, our studies have demonstrated that rat DRG cells release PGE2 in response to BK stimulation by two different mechanisms. Although both are mediated by B2 receptors, one is due to COX-1 activity in short-term treatment with BK and the other is mainly due to the induction of COX-2 in long-term treatment. These results are consistent with the hypothesis that COX-1 is a constitutive isoform, while COX-2 is an inducible isoform responsible for the generation of prostanoids under inflammatory conditions. Since peripheral inflammation induces the local production of kinin and proinflammatory cytokines, and since IL-1β [12] and BK have been shown to induce COX-2 protein, which may cause prostanoid generation, this may play an important role in the pathogenesis of inflammatory pain and hyperalgesia around primary afferent neurons. A. Inoue et al. Fig. 3 
